Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Anaergia Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anaergia şirketinin toplam hissedar öz sermayesi CA$69.5M ve toplam borcu CA$60.4M olup, bu da borç-öz sermaye oranını 86.9% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CA$250.7M ve CA$181.2M dir.

Anahtar bilgiler

86.9%

Borç/özkaynak oranı

CA$60.43m

Borç

Faiz karşılama oranı	n/a
Nakit	CA$39.57m
Eşitlik	CA$69.51m
Toplam yükümlülükler	CA$181.23m
Toplam varlıklar	CA$250.74m

Son finansal sağlık güncellemeleri

Does Anaergia (TSE:ANRG) Have A Healthy Balance Sheet?

Sep 18

Recent updates

Need To Know: Analysts Just Made A Substantial Cut To Their Anaergia Inc. (TSE:ANRG) Estimates

May 16

Earnings Update: Anaergia Inc. (TSE:ANRG) Just Reported And Analysts Are Trimming Their Forecasts

May 14

Analysts Just Made A Major Revision To Their Anaergia Inc. (TSE:ANRG) Revenue Forecasts

Nov 13

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: ANRG 'nin kısa vadeli varlıkları ( CA$120.0M ) kısa vadeli yükümlülüklerini ( CA$104.3M ) aşıyor.

Uzun Vadeli Yükümlülükler: ANRG şirketinin kısa vadeli varlıkları ( CA$120.0M ) uzun vadeli yükümlülüklerini ( CA$77.0M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: ANRG 'nin net borç/öz sermaye oranı ( 30% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: ANRG şirketinin borç/öz sermaye oranının son 5 yılda azalıp azalmadığını belirlemek için yeterli veri yok.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: ANRG şirketinin mevcut serbest nakit akışına göre bir yıldan fazla yetecek nakit pisti bulunmaktadır.

Tahmini Nakit Akışı: ANRG un, serbest nakit akışı her yıl % 6.8 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

Anaergia Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Does Anaergia (TSE:ANRG) Have A Healthy Balance Sheet?

Recent updates

Anaergia Inc.'s (TSE:ANRG) 31% Jump Shows Its Popularity With Investors

Interim Chief Financial Officer recently bought CA$78k worth of stock

Does Anaergia (TSE:ANRG) Have A Healthy Balance Sheet?

Independent Director recently bought CA$61k worth of stock

Executive Director recently bought CA$109k worth of stock

Anaergia Inc. Announces Appointment of Gregory Wolf, Interim Chief Financial Officer to Permanent Chief Financial Officer

Second quarter 2024 earnings released: CA$0.04 loss per share (vs CA$1.78 loss in 2Q 2023)

Anaergia Inc. (TSE:ANRG) Soars 92% But It's A Story Of Risk Vs Reward

Less than half of directors are independent

Anaergia Inc. Announces Chairman Changes

First quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.17 loss in 1Q 2023)

Less than half of directors are independent

Anaergia Inc. Announces CEO Changes

Anaergia Inc. Announces Resignation of Frank Mckenna as Board of Directors

Anaergia Inc., Annual General Meeting, Jun 24, 2024

Less than half of directors are independent

Anaergia Inc. Announces Board Changes

Price target decreased by 20% to CA$0.33

New major risk - Shareholder dilution

Anaergia Inc. announced that it expects to receive CAD 40.8 million in funding from Marny Holdco

Anaergia Inc. announced that it expects to receive CAD 40.8 million in funding from Marny Holdco

Anaergia Inc. announced that it expects to receive CAD 40.8 million in funding from Marny Holdco

New minor risk - Profitability

Forecast breakeven date pushed back to 2025

Insufficient new directors

Anaergia Inc. to Report Q3, 2023 Results on Nov 14, 2023

SMK Law P.C. and Bates Barristers Announces an Amended Statement of Claim Has Been Filed in the Proposed Class Action Lawsuit Against Anaergia Inc

SMK Law P.C. and Bates Barristers Announces an Amended Statement of Claim Has Been Filed in the Proposed Class Action Lawsuit Against Anaergia Inc

Anaergia Inc. Withdraws Earnings Guidance for the Fiscal Year 2023

Forecast breakeven date pushed back to 2025

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Anaergia Inc. to Report Q2, 2023 Results on Aug 14, 2023

Price target increased by 9.1% to CA$2.29

Price target decreased by 25% to CA$2.10

Anaergia Inc. Announces CEO Changes

Anaergia Inc. Announces Appointment of Andrew Spence as Chief Financial Officer

Need To Know: Analysts Just Made A Substantial Cut To Their Anaergia Inc. (TSE:ANRG) Estimates

Earnings Update: Anaergia Inc. (TSE:ANRG) Just Reported And Analysts Are Trimming Their Forecasts

Price target increased by 16% to CA$5.48

Anaergia Inc. Updates Earnings Guidance for the Fiscal Year of 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 7.3% to CA$4.73

Consensus EPS estimates have been downgraded.

Consensus EPS estimates have been downgraded.

Price target decreased by 11% to CA$7.56

Insufficient new directors

Price target decreased by 7.1% to CA$8.53

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Analysts Just Made A Major Revision To Their Anaergia Inc. (TSE:ANRG) Revenue Forecasts

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to CA$17.29

Anaergia Inc. Revises Revenue Guidance for Fiscal 2022

Anaergia Inc. to Report Q3, 2022 Results on Nov 10, 2022

Anaergia Inc. Appoints Paula Myson as Chief Financial Officer

Anaergia Inc. Reaffirms Financial Guidance for the Fiscal 2022 and Fiscal 2023

Anaergia Inc. to Report Q2, 2022 Results on Aug 15, 2022

Anaergia Inc. to Report Q2, 2022 Results on Aug 15, 2022

Anaergia Inc. Announces Executive Changes

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Consensus forecasts updated

Executive Chairman & CEO recently bought CA$5.0m worth of stock

Executive Chairman & CEO recently bought CA$5.0m worth of stock

Anaergia Inc. to Report Q1, 2022 Results on May 12, 2022

Anaergia Inc. has completed a Follow-on Equity Offering in the amount of CAD 60 million.

Anaergia Inc., Annual General Meeting, Jun 17, 2022

Full year 2021 earnings: Revenues exceed analyst expectations

Anaergia Inc. Provides Earnings Guidance for the Fiscal Year 2022 and 2023

Anaergia Inc. to Report Q4, 2021 Results on Mar 28, 2022

Anaergia Inc. has completed an IPO in the amount of CAD 175 million.

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin